Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lundsgaard-Hansen

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Annals of Clinical Research|January 1, 1981
Colloids versus crystalloids as volume substitutes: clinical relevance of the serum oncotic pressureP Lundsgaard-Hansen, E Pappova
Current Studies in Hematology and Blood Transfusion|January 1, 1992
Markers and mediators in enterogenic infectious-toxic shockP Lundsgaard-Hansen, B Blauhut
Vox Sanguinis|January 1, 1978
The procurement of blood and plasma for the production of components and derivatives within the frame on an integrated National Blood ProgramA Hässig, P Lundsgaard-Hansen
British Journal of Hospital Medicine|March 1, 1988
Role of the reticuloendothelial system in the pathogenesis of organ damageJ E Doran, P Lundsgaard-Hansen
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1987
Plasma fibronectin in abdominal sepsis and shock: therapeutic and prognostic valueJ E Doran, P Lundsgaard-Hansen
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1993
[Drug modification of blood loss]B Blauhut, P Lundsgaard-Hansen, S Necek
Developments in Biological Standardization|January 1, 1980
Clinical indications for human serum albuminP Lundsgaard-Hansen, E Pappova, E Frei
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Review. The intensive medical care relevance of plasma fibronectin]P Lundsgaard-Hansen, J E Doran, E Rubli
Infusionstherapie (Basel, Switzerland)|August 1, 1989
Is there a generally valid, minimum acceptable hemoglobin level?P Lundsgaard-Hansen, J E Doran, B Blauhut
Intensive Care Medicine|January 1, 1986
Plasma fibronectin: relevance for anesthesiology and intensive careJ E Doran, P Lundsgaard-Hansen, E Rubli
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Annals of Clinical Research|January 1, 1981
Colloids versus crystalloids as volume substitutes: clinical relevance of the serum oncotic pressureP Lundsgaard-Hansen, E Pappova
Current Studies in Hematology and Blood Transfusion|January 1, 1992
Markers and mediators in enterogenic infectious-toxic shockP Lundsgaard-Hansen, B Blauhut
Vox Sanguinis|January 1, 1978
The procurement of blood and plasma for the production of components and derivatives within the frame on an integrated National Blood ProgramA Hässig, P Lundsgaard-Hansen
British Journal of Hospital Medicine|March 1, 1988
Role of the reticuloendothelial system in the pathogenesis of organ damageJ E Doran, P Lundsgaard-Hansen
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1987
Plasma fibronectin in abdominal sepsis and shock: therapeutic and prognostic valueJ E Doran, P Lundsgaard-Hansen
Klinische Anasthesiologie Und Intensivtherapie|January 1, 1993
[Drug modification of blood loss]B Blauhut, P Lundsgaard-Hansen, S Necek
Developments in Biological Standardization|January 1, 1980
Clinical indications for human serum albuminP Lundsgaard-Hansen, E Pappova, E Frei
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
[Review. The intensive medical care relevance of plasma fibronectin]P Lundsgaard-Hansen, J E Doran, E Rubli
Infusionstherapie (Basel, Switzerland)|August 1, 1989
Is there a generally valid, minimum acceptable hemoglobin level?P Lundsgaard-Hansen, J E Doran, B Blauhut
Intensive Care Medicine|January 1, 1986
Plasma fibronectin: relevance for anesthesiology and intensive careJ E Doran, P Lundsgaard-Hansen, E Rubli
Pageof 7